11/15
Genetics
Neanderthals carried genes acquired from ancient interactions with ‘cousins’ of modern humans
Neanderthals carried genes acquired from ancient interactions with ‘cousins’ of modern humans
A new collaborative study led by Sarah Tishkoff shows that Neanderthals inherited at least 6% of their genome from a now-extinct lineage of early modern humans.
An unsolved mystery: Why are we sleepy when sick?
An unsolved mystery: Why are we sleepy when sick?
David Raizen, a professor of neurology, alongside PURM student Hina Sako, spent the summer moving forward research examining how sickness affects sleep.
Genetic switch turns tumor suppressor into oncogene in colorectal cancer
Genetic switch turns tumor suppressor into oncogene in colorectal cancer
Researchers from the School of Veterinary Medicine have shown that an enzyme that suppresses early-stage colorectal cancer switches to become an oncogene as the cancer progresses.
‘In vivo’ RNA-based gene editing model for blood disorders developed
‘In vivo’ RNA-based gene editing model for blood disorders developed
Researchers from Penn Medicine and The Children’s Hospital of Philadelphia show that gene editing tools can be delivered via lipid nanoparticles, which would reduce cost and increase access to cutting-edge gene therapies.
Katalin Susztak hunts for a cure for kidney disease
Katalin Susztak hunts for a cure for kidney disease
Throughout her career, the professor of internal medicine, nephrology, and genetics has had a profound impact on the way kidney disease is identified, prevented, and managed.
A better understanding into how genes make us prone to allergies
A better understanding into how genes make us prone to allergies
Slight alterations in the ETS1 protein level can lead to allergic inflammation.
Three things to know about BRCA mutations in men
Three things to know about BRCA mutations in men
Kara Maxwell, director of the Men & BRCA Program at the Basser Center, is bridging the knowledge gap about how BRCA mutations affect men.
Improved gene editing method could power future cell and gene therapies
Improved gene editing method could power future cell and gene therapies
A new technique based on special cell-penetrating peptides promises advantages over current methods for editing the genomes of primary cells, such as patients’ T cells.
Four from Penn awarded Helen Keller Prize for Vision Research
Four from Penn awarded Helen Keller Prize for Vision Research
Faculty from the School of Veterinary Medicine and Perelman School of Medicine were honored at the Association for Research in Vision and Ophthalmology meeting in New Orleans.
Biological test detects Parkinson’s disease before symptoms present
Biological test detects Parkinson’s disease before symptoms present
Penn Medicine research shows this test can detect a build-up of abnormal protein deposits linked to Parkinson’s disease in cerebrospinal fluid.
In the News
Philadelphia Inquirer
A Philly biotech got $60M from a TED initiative for AI in medicine
David Fajgenbaum of the Perelman School of Medicine helped found Every Cure, a biotechnology nonprofit that employs AI to help match existing treatments to new diseases.
FULL STORY →
Stat
Study of gender-affirming care reveals immune system sex differences
Montserrat Anguera of the Perelman School of Medicine and the School of Veterinary Medicine comments on the work to comprehensively examine the impact of gender-affirming care on the immune system.
FULL STORY →
The New York Times
A disease that makes children age rapidly gets closer to a cure
Kiran Musunuru of the Perelman School of Medicine says there’s no guarantee that gene editing which worked well in mice will also work with human patients.
FULL STORY →
USA Today
She’s fighting to stop the brain disease that killed her mother before it gets her
Kiran Musunuru of the Perelman School of Medicine comments on shutting off genetic signals in the brain to hold off diseases.
FULL STORY →
The Washington Post
FDA approves two sickle cell therapies, including first CRISPR medicine
Kiran Musunuru of the Perelman School of Medicine says that gene editing will be the biggest story of the century.
FULL STORY →
Philadelphia Inquirer
More than 260,000 Penn Medicine patients have agreed to share their DNA for research, and the discoveries are just getting started
More than 260,000 people have signed up to participate in Penn Medicine BioBank, co-directed by Marilyn Ritchie and Dan Rader, which cross-references DNA with electronic health records to discover genetic variants of medical conditions.
FULL STORY →